Staburo took part in the BVMA symposium on 25 November 2022, at the Westin Grand Hotel, here in Munich. This year it was the 30. BVMA symposium and for this anniversary the get-together took place the evening before at the SEA LIFE aquarium in Munich.
Since our team grew substantially, we searched, appointed, and enabled a bigger management team at Staburo, consisting of two heads (of departments) and six directors (focus on data science topics). We want to give them a chance to talk about themselves and their passion! Therefore, we publish a mini news series about the management team members and will continue with our Director Data Science and Diagnostics, Stefan Bentink.
Staburo’s Managing Director Roland Stieger joined the BIO-Europe last week and enjoyed the great networking opportunities of this partnering conference with approx. 4800 delegates!
In addition to several one-on-one meetings, in which Roland discussed data science challenges of potential partners, there were panel discussions, e.g. about changes in Health Technology Assessment in Europe with Florian Diwischek (Novartis) and Fabian Berkemeier (IGES).
Since our team grew substantially, we searched, appointed, and enabled a bigger management team at Staburo, consisting of two heads (of departments) and six directors (focus on data science topics). We want to give them a chance to talk about themselves and their passion! Therefore, we publish a mini news series about the management team members and will continue with our Head of Business Unit, Katrin Frank.
It is a very nice Staburo tradition to go to the traditional Munich Oktoberfest together. The last two years the “Wiesn” was cancelled but this year it took part again and we decided to go and had a reservation for the Bräurosl tent!
The gold standard for evaluating medical interventions is a randomised clinical trial with statistical analysis based on the intention-to-treat population. However, even if a randomised clinical trial is well planned, post-randomisation events occur and affect or even challenge the interpretation and validity of the study results.
To celebrate the 10th anniversary of Staburo GmbH, we organised a summer party. It was a great pleasure to spend this special day with almost 120 people – employees & their families, friends, and other companions.
In 2021, the corona pandemic forced us to think creatively. We wanted to continue the run but as something less anonymous that still sticks to the safety regulations. Based on these conditions, we quickly designed our own internal company run in 2021 with the aim to encourage the sporty spirit in us, reconnect with colleagues, and find a complement to our usually sedentary tasks.
Staburo supported an exploratory analysis of the mRNA-1273 Phase 1 Trial to assess the clinical utility of the quantitative Roche Elecsys® Anti-SARS-CoV-2 S assay (ACOV2S). Geometric mean concentrations as well as seroconversion over time was assessed overall and by dose and age group.
Since our team grew substantially, we searched, appointed, and enabled a bigger management team at Staburo, consisting of two heads (of departments) and six directors (focus on data science topics). Here, we want to give them a chance to talk about themselves and their passion! Therefore, we publish a mini news series about the management team members and will continue with our director director bioinformatics and data analytics, Dr. Janine Roy.
Nine Staburo colleagues recently took part in a full-day first aid course that was organized in collaboration with the company Springer Medicine publishing, who is a neighbor company in our Munich office building.
Two posters by Staburo members were presented at the PSI 2022 conference in Gothenburg, Sweden. The conference, regarded as the principal annual event of the statisticians in the pharmaceutical industry, took place as face-to-face event from 12th to 15th of June in the Gothia Towers.